companydata.dkcompanydata.dk

Copenhagen Pharma Consulting ApS: Financial statements 2025

CVR: 41537388

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Copenhagen Pharma Consulting ApS (CVR 41537388) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. That is an increase of 28.5% compared with the year before. Equity in the 2025 report amounted to DKK 601,867. The solvency ratio was 41.4%. The company had 2 employees in the financial year.

Gross Profit
DKK 3,364,006
Profit/Loss
DKK 419,568
Equity
DKK 601,867
Total Assets
DKK 1,455,343
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-3.4M420K602K2
2024-2.6M558K1.7M2
2023-2.9M336K1.2M2
2022-1.3M-38K906K2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Copenhagen Pharma Consulting ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Copenhagen Pharma Consulting ApS: The 2024 annual report is outMar 25, 2025

Copenhagen Pharma Consulting ApS has published its annual report for 2024. Gross profit came to DKK 2,617,035, and the net result was DKK 558,252.

About Copenhagen Pharma Consulting ApS

Copenhagen Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2020. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Lars Holten-Andersen. The company is owned by Obi1 Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. Equity in the 2025 report amounted to DKK 601,867.

Source: annual report 2025, Danish Business Authority

Other financial years